Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
An abnormal red blood cell count can occur with leukemia or bone marrow disorders, but it is far more often caused by common, treatable conditions such as iron or B12 deficiency, dehydration, chronic kidney disease, thyroid problems, blood loss, smoking, sleep apnea, or living at high altitude. Blood cancers and marrow failure syndromes like myelodysplastic syndrome or aplastic anemia usually disturb more than one cell line, so doctors look for low platelets, abnormal white cells, immature or blast cells on a smear, and symptoms like unexplained bruising, recurrent infections, drenching night sweats, bone pain, swollen lymph nodes, or weight loss. A single out-of-range value on one test, without these red flags, rarely indicates cancer and is often rechecked before any further workup. Which follow-up tests matter, including a repeat CBC, reticulocyte count, iron and vitamin studies, peripheral smear, or referral for bone marrow biopsy, depends on the pattern of your results and your personal risk factors. There are several important factors to consider, so see below to understand more.
Because RBC results only make sense alongside your full blood panel and symptoms, the fastest way to know whether your numbers point to something benign or something that needs urgent evaluation is to review the whole picture rather than one number. A free, instant, online symptom check takes just a few minutes, asks the same questions a clinician would ask, and helps you identify which possible causes fit your situation and how soon you should be seen. Use it to walk into your next appointment with clear, organized information and better questions.
Last reviewed for medical accuracy: 09/12/2026
A red blood cell (RBC) blood test is one of the most common ways to check your overall health. RBCs carry oxygen from your lungs to the rest of your body. An unusually low or high RBC count can signal various health issues—including, in some cases, leukemia or other bone marrow disorders. This guide will help you understand what an abnormal RBC count means, when to worry, and what steps to take next.
An RBC blood test is part of a Complete Blood Count (CBC). It measures:
Normal ranges can vary slightly by lab, but typical adult ranges are:
Values outside these ranges are labeled as:
Anemia is the general term for a low RBC count or low hemoglobin. Common causes include:
A high RBC count can occur when your body attempts to compensate for low oxygen or makes too many RBCs. Causes include:
Leukemia is a cancer of the blood-forming tissues. In many types of leukemia:
However, a low RBC count alone does not confirm leukemia. Many other conditions cause anemia.
A variety of bone marrow diseases can also lead to abnormal RBC counts:
In these disorders, an abnormal RBC count is one piece of the puzzle. Your doctor will look at:
An abnormal RBC count is not a diagnosis by itself. But you should pay close attention if you have:
These symptoms—especially when combined with abnormal values on your CBC—warrant further evaluation.
Only with a complete workup can a definitive diagnosis—whether anemia from nutrition, chronic disease, leukemia, or another marrow disorder—be made.
It’s natural to feel anxious about abnormal lab results. Keep in mind:
If you’re unsure what your test results mean, you might consider taking a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you figure out next steps before you see a clinician. Try the Ubie Symptom Checker
Abnormal RBC counts can be a clue to something minor or serious. Always speak to a doctor if you have:
Only a healthcare professional can interpret your RBC blood test in the context of your overall health and order the appropriate follow-up tests.
Key Takeaway: An abnormal RBC count on an RBC blood test may reflect a range of issues—from simple nutritional deficiencies to more serious bone marrow diseases like leukemia. The RBC count is one part of a complete blood picture. If you see unusual results or experience troubling symptoms, speak to a doctor. Your physician can guide further testing, treatment, or specialist referral to get to the root cause and ensure you receive the care you need.
(References)
* Hathaway JE. Feline anemia. Vet Clin North Am. 1976 Aug;6(3):495-510. doi: 10.1016/s0091-0279(76)50066-9. PMID: 183337.
* Strickland RW, Vukelja SJ, Wohlgethan JR, Canoso JJ. Hemorrhagic subcutaneous bursitis. J Rheumatol. 1991 Jan;18(1):112-4. PMID: 2023179.
* Atkins JN, Muss HB. Schistocytes in erythroleukemia. Am J Med Sci. 1985 Mar;289(3):110-3. doi: 10.1097/00000441-198503000-00004. PMID: 3856384.
* Schneider H, Jobke A, Niederhoff H, Künzer W. [Transient erythroblastopenia]. Klin Padiatr. 1985 Jan-Feb;197(1):9-12. doi: 10.1055/s-2008-1033918. PMID: 3974170.
* Brouillard RP. Ineffective erythropoiesis. Med Ann Dist Columbia. 1973 Nov;42(11):563-5. PMID: 4520011.
* WALLERSTEIN RO, AGGELER PM. ACUTE HEMOLYTIC ANEMIA. Am J Med. 1964 Jul;37:92-104. doi: 10.1016/0002-9343(64)90214-1. PMID: 14181152.
* Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009 Feb 1;79(3):203-8. PMID: 19202968.
* Ramos P, Casu C, Gardenghi S, Breda L, Crielaard BJ, Guy E, Marongiu MF, Gupta R, Levine RL, Abdel-Wahab O, Ebert BL, Van Rooijen N, Ghaffari S, Grady RW, Giardina PJ, Rivella S. Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia. Nat Med. 2013 Apr;19(4):437-45. doi: 10.1038/nm.3126. Epub 2013 Mar 17. PMID: 23502961; PMCID: PMC3618568.
* Suragani RN, Cadena SM, Cawley SM, Sako D, Mitchell D, Li R, Davies MV, Alexander MJ, Devine M, Loveday KS, Underwood KW, Grinberg AV, Quisel JD, Chopra R, Pearsall RS, Seehra J, Kumar R. Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat Med. 2014 Apr;20(4):408-14. doi: 10.1038/nm.3512. Epub 2014 Mar 23. PMID: 24658078.
* de Castro C, Kelly RJ, Griffin M, Patriquin CJ, Mulherin B, Höchsmann B, Selvaratnam V, Wong RSM, Hillmen P, Horneff R, Uchendu UO, Zhang Y, Surova E, Szamosi J, de Latour RP. Efficacy and Safety Maintained up to 3 Years in Adults with Paroxysmal Nocturnal Hemoglobinuria Receiving Pegcetacoplan. Adv Ther. 2025 Sep;42(9):4641-4658. doi: 10.1007/s12325-025-03310-8. Epub 2025 Jul 28. PMID: 40720060; PMCID: PMC12394272.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.